Literature DB >> 31398004

Multiple Reaction Monitoring Profiling (MRM-Profiling) of Lipids To Distinguish Strain-Level Differences in Microbial Resistance in Escherichia coli.

Zhuoer Xie1, L Edwin Gonzalez1, Christina R Ferreira1,2, Anna Vorsilak3, Dylan Frabutt3, Tiago J P Sobreira2, Michael Pugia3, R Graham Cooks1.   

Abstract

The worldwide increase in antimicrobial resistance is due to antibiotic overuse in agriculture and overprescription in medicine. For appropriate and timely patient support, faster diagnosis of antimicrobial resistance is required. Current methods for bacterial identification rely on genomics and proteomics and use comparisons with databases of known strains, but the diagnostic value of metabolites and lipids has not been explored significantly. Standard mass spectrometry/chromatography methods involve multiple dilutions during sample preparation and separation. To increase the amount of chemical information acquired and the speed of analysis of lipids, multiple reaction monitoring profiling (MRM-Profiling) has been applied. The MRM-Profiling workflow includes a discovery stage and a screening stage. The discovery stage employs precursor (PREC) ion and neutral loss (NL) scans to screen representative pooled samples for functional groups associated with particular lipid classes. The information from the first stage is organized in precursor/product ion pairs, or MRMs, and the screening stage rapidly interrogates individual samples for these MRMs. In this study, we performed MRM-Profiling of lipid extracts from four different strains of Escherichia coli cultured with amoxicillin or amoxicillin/clavulanate, a β-lactam and β-lactamase inhibitor, respectively. t tests, analysis of variance and receiver operating characteristic (ROC) curves were used to determine the significance of each MRM. Principal component analysis was applied to distinguish different strains cultured under conditions that allowed or disallowed development of bacterial resistance. The results demonstrate that MRM-Profiling distinguishes the lipid profiles of resistant and nonresistant E. coli strains.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31398004     DOI: 10.1021/acs.analchem.9b02465

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Adaption of the Aristotle Classifier for Accurately Identifying Highly Similar Bacteria Analyzed by MALDI-TOF MS.

Authors:  Heather Desaire; David Hua
Journal:  Anal Chem       Date:  2019-12-10       Impact factor: 6.986

Review 2.  Review of non-invasive detection of SARS-CoV-2 and other respiratory pathogens in exhaled breath condensate.

Authors:  Emeka Nwanochie; Jacqueline C Linnes
Journal:  J Breath Res       Date:  2022-03-18       Impact factor: 4.538

3.  Mechanistic Studies and In Vivo Efficacy of an Oxadiazole-Containing Antibiotic.

Authors:  George A Naclerio; Nader S Abutaleb; Kenneth I Onyedibe; Caroline Karanja; Hassan E Eldesouky; Hsin-Wen Liang; Alexandra Dieterly; Uma K Aryal; Tiffany Lyle; Mohamed N Seleem; Herman O Sintim
Journal:  J Med Chem       Date:  2022-04-28       Impact factor: 8.039

4.  Exacerbation of Nanoparticle-Induced Acute Pulmonary Inflammation in a Mouse Model of Metabolic Syndrome.

Authors:  Saeed Alqahtani; Lisa M Kobos; Li Xia; Christina Ferreira; Jackeline Franco; Xuqin Du; Jonathan H Shannahan
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

5.  Development of nanoparticles derived from corn as mass producible bionanoparticles with anticancer activity.

Authors:  Daisuke Sasaki; Kosuke Kusamori; Yukiya Takayama; Shoko Itakura; Hiroaki Todo; Makiya Nishikawa
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

6.  Multiple reaction monitoring profiling as an analytical strategy to investigate lipids in extracellular vesicles.

Authors:  Madison E Edwards; Thomas De Luca; Christina R Ferreira; Kimberly S Collins; Michael T Eadon; Eric A Benson; Tiago J P Sobreira; Robert Graham Cooks
Journal:  J Mass Spectrom       Date:  2020-11-18       Impact factor: 1.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.